Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.60 |
| ▸ | RAB9A | P51151 | 6/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxolamine SCHEMBL1652318 | 0.98 | HTR1A (0.97) | HTR1AHRH3CYP1A2CYP2D6HIF1A | |
| Oxolamine SCHEMBL4414451 | 0.86 | CYP1A2 (0.78) | HTR1AHRH3CYP1A2CYP2D6HIF1A | |
| Oxolamine SCHEMBL3498928 | 0.85 | CYP1A2 (1.00) | HTR1AHRH3CYP1A2CYP2D6HIF1A | |
| SCHEMBL7947228 | 0.84 | HTR1A (0.73) | HTR1AHRH3CYP1A2CYP2D6HIF1A | |
| SCHEMBL29376403 | 0.83 | HTR1A (0.71) | HTR1AHRH3CYP1A2CYP2D6HIF1A | |
| SCHEMBL14288613 | 0.82 | RAB9A (0.70) | HTR1AHRH3CYP1A2L3MBTL1RAB9A | |
| SCHEMBL7961634 | 0.79 | HTR1A (0.65) | HTR1AHRH3CYP1A2L3MBTL1RAB9A | |
| SCHEMBL91541 | 0.79 | NOTUM (0.68) | HTR1AHRH3CYP1A2L3MBTL1RAB9A | |
| Dimethylamine SCHEMBL7961636 | 0.78 | HTR1A (0.64) | HTR1AHRH3CYP1A2L3MBTL1RAB9A | |
| SCHEMBL7961648 | 0.78 | HTR1A (0.63) | HTR1AHRH3CYP1A2L3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119948030-A | Protease/enzyme cleavable linker-payload and protein conjugates | 苏特罗生物制药公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119855614-A | Beta-glucuronide linker-payload, protein conjugates thereof and methods thereof | 苏特罗生物制药公司 | 2025-04-18 | — | — | CN | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| US-12102653-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2024-10-01 | — | — | US | claimed |
| CN-118206634-A | Ligand-regulated protein-protein interaction system | 圣安娜儿童癌症研究中心 | 2024-06-18 | — | — | CN | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| EP-1651184-A1 | FAST DISSOLVING ORALLY CONSUMABLE FILMS CONTAINING PHARMACEUTICALLY ACTIVE AGENTS | Warner-Lambert Company LLC (US) | 2006-05-03 | — | — | EP | claimed |
| CN-1750809-A | Fast dissolving orally consumable films containing pharmaceutically active agents | WARNER LAMBERT CO (US) | 2006-03-22 | — | — | CN | claimed |
| WO-2004096174-A1 | FAST DISSOLVING ORALLY CONSUMABLE FILMS CONTAINING PHARMACEUTICALLY ACTIVE AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-11-11 | — | — | WO | claimed |
| US-6699841-B2 | ADDING TRISUBSTITUTED SALT OF GLYCYRRHIZIC ACID TO AQUEOUS SOLTUION OF FIRST PHYSIOLOGICALLY ACCEPTABLE COMPOUND OF AN ACIDIC NATURE, AND SECOND PHYSIOLOGICALLY ACCEPTABLE COMPOUND OF A BASIC NATURE | BAIOCCHI LEANDRO (IT) | 2004-03-02 | — | — | US | claimed |
| US-20030206942-A1 | Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent | MCNEIL-PPC, INC | 2003-11-06 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-20020193322-A1 | Method of preparing physiologically acceptable aqueous solutions, and solutions thus obtained | BAIOCCHI LEANDRO (IT) | 2002-12-19 | — | — | US | claimed |
| EP-1226831-A1 | Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts | Baiocchi, Leandro (IT) | 2002-07-31 | — | — | EP | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |